The slip
PARKINSON RECEIPTno. 6834
22 Oct 2026, 21:35 UTCdopamine neurons, braak
predictionNTHL1 in dopamine neurons tracks Braak Lewy-body stage
registeredc7d61f6beac7f92c
discovery+0.21 p=0.586 n=9
replication-0.35 p=0.354 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.21, p 0.586)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT1f1238c37d25a7c232aa9558…
follows 196dd5d7908b…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6834: NTHL1 in dopamine neurons, braak
- power
- full sample -0.01 (p 0.976, n 18), 95% CI -0.47 to +0.46. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.04 (p 0.861, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.29 (p 0.235, n 18). could be the mix.
- skeptic
- leave-one-out range -0.13 to +0.12, sign flips 6; without severely affected donors -0.01 (p 0.976, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.63 (p 0.0055, n 18) vs -0.01 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NTHL1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up NTHL1 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.25 p 0.374 (needs p < 3.0e-4)